Resonate Blends, Inc. (KOAN) Stock
APOLLO BioWellness Inc. focuses its efforts on researching, formulating, and bringing to market products designed for human health within the regenerative medicine sector.
Valuation
Financials & Margins
Annual Financials (USD)
Balance Sheet (USD)
Cash Flow (USD)
Valuation & Return Ratios
Ownership
Peer Comparison
About Resonate Blends, Inc.
APOLLO BioWellness Inc. focuses its efforts on researching, formulating, and bringing to market products designed for human health within the regenerative medicine sector. A significant part of its operations involves the commercialization of licensed, naturally derived compounds currently awaiting patent approval, which are specifically engineered to boost an individual's innate capacity to mobilize adult stem cells from their own bone marrow. Additionally, the firm possesses the marketing rights for an all-natural, two-pronged dietary supplement crafted to help regulate hunger by engaging the body's intrinsic signaling pathways between the brain and the digestive system. Beyond its current offerings, the company is also deeply involved in research and development initiatives. These efforts are dedicated to exploring new frontiers, such as Secretogues aimed at enhancing a person's endogenous growth hormone synthesis, along with other natural bioactive formulations intended to optimize human physiological performance. This is achieved by harnessing the body's own biological mechanisms, entirely without the use of pharmaceutical drugs. The company maintains its corporate headquarters in North Bergen, New Jersey.
Resonate Blends, Inc. (KOAN) stock trades at $0.00 with a market capitalization of $97625. The stock is valued at a price-to-earnings (P/E) ratio of -0.05, price-to-book of -0.03, price-to-sales of 0.08. Over the past 52 weeks the stock has ranged between $0.00 and $0.02, and currently trades 100.0% below its 52-week high.
On profitability, Resonate Blends, Inc. generates a return on equity (ROE) of 40.00% — well above the market average, a sign of a high-quality business, return on capital employed of 16.51%, an operating margin of -76.66%, a net profit margin of 51.23%.
Official website: www.apollobiowellness.com